HomeNewsBusinessNHSRC officials say Mumbai-Ahmedabad High-Speed Rail project likely to be completed by 2028

NHSRC officials say Mumbai-Ahmedabad High-Speed Rail project likely to be completed by 2028

The first phase of the project is expected to be launched in 2026. The high-speed rail project is being constructed with 80 percent loan from Japan at 0.1 percent interest and a 15-year moratorium.

July 21, 2022 / 19:52 IST
Story continues below Advertisement
Representative image.
Representative image.

Officials from the National High-Speed Rail Corp (NHSRC) told Moneycontrol that they expect the execution of the bullet train project in India to be completed by 2028, with the first phase of the project expected to be launched in 2026.

"The government is confident of completing land acquisition by the end of the year, and project execution in Maharashtra will pick up significantly after land acquisition for the project will be completed," a senior official from the company said.

Story continues below Advertisement

While 99 percent of the land required for the project has been obtained in Gujarat and Dadra Nagar Haveli, only 68 percent has been acquired in Maharashtra, officials said. NHSRC has, for the last few years, struggled to acquire land in the Thane Creek area of Maharashtra, where a 21-km tunnel, which includes a 7-km undersea section, is proposed.

Senior officials from the NHSRC said that they are targeting to complete the 384-km section of India's bullet train project in Gujarat by 2027, and then shift their focus to the section in Maharashtra.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show